跳至主要内容
临床试验/EUCTR2020-001285-11-NL
EUCTR2020-001285-11-NL
进行中(未招募)
1 期

A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy – A strategy trial - LAX

eiden University Medical Center0 个研究点目标入组 100 人2020年11月13日
相关药物CymbaltaVimpat

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
eiden University Medical Center
入组人数
100
状态
进行中(未招募)
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2020年11月13日
结束日期
待定
最后更新
3年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
eiden University Medical Center

入排标准

入选标准

  • 1\.Age\> 18 years
  • 2\.Able to give oral and written informed consent
  • 3\.Presence of CIPN grade 1 or higher according to the NCIC\-CTC
  • 4\.Pain score of 45 or higher
  • 5\.Chemotherapy with taxanes, platinums, vincalkinioids or bortezomib in the last 2 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 60
  • F.1\.3 Elderly (\>\=65 years) yes

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study
  • 1\.Allergy to the study medication
  • 2\.Epilepsy
  • 3\.History of illicit drug or alcohol abuse
  • 4\.History of psychosis
  • 5\.Pregnancy or lactation
  • 6\.Use of anti\-epileptic or anti\-depressant medication
  • 7\.Concomittant neuropathy other than chemotherapy\-induced
  • 8\.Moderate and severe liver enzyme abnormalities
  • 9\.Kidney dysfunction (GFR \< 30 mL/min)

结局指标

主要结局

未指定

相似试验